Veradermics MANE
NYSE MANE
$148.65 +4.70 (+3.27%)
As of: Nov 10, 2026 · 12:50 PM EST

Veradermics (MANE) Share-based Compensation (2025 - 2026)

Updated

Veradermics' Share-based Compensation came in at $3.52 million for Q2 2026, compared with $115,000 a year earlier and down 33.1% from the prior quarter.

Analysis

Veradermics (MANE) Share-based Compensation (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported Share-based Compensation of $9.1 million; for FY2025, it was $1.44 million, up 476.0% from FY2024.

  • Going back by year, Share-based Compensation was $250,000 in FY2024.
  • The five-year range for quarterly Share-based Compensation is $115,000 (Q2 2025) to $5.26 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Veradermics 6.01 Bn 4.61 Bn - 3.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.52 Mn
Mar 31, 2026 5.26 Mn
Jun 30, 2025 115,000.00
Mar 31, 2025 213,000.00
API Access

Veradermics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MANE&period=max&api_key=YOUR_API_KEY